Aandelen in “Medicinale en botanische productie”

Aandeel Datum Koers Evolutie
Even geduld...

Nieuws over “Medicinale en botanische productie”

07:00 · Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate · Persbericht

07:00 · Ipsen expands early development pipeline with Simcere Zaiming’s innovative antibody drug conjugate · Persbericht

19/12 · Novartis and US government reach agreement on lowering drug prices in the US · Persbericht

19/12 · Presidential Executive Order Validates DeFloria's Strategy in Pharmaceutical Cannabinoid Drug Development · Persbericht

19/12 · Ipsen update on Phase II FALKON trial in patients with ultra-rare bone disease, fibrodysplasia ossificans progressiva (FOP) · Persbericht

18/12 · High Tide Welcomes Historic Executive Order on Cannabis Rescheduling and Medicare Reimbursements for CBD Products · Persbericht

18/12 · Charlotte's Web Serves as a Premier CBD Partner for Landmark Medicare and Medicaid Pilot Program · Persbericht

18/12 · AB Science announces the initiation of coverage of its stock by Maxim Group with a target price of EUR 4.0 per share · Persbericht

18/12 · Aurora Launches Daily Special™ in Germany, Delivering High-Quality, Affordable Medical Cannabis to Patients · Persbericht

17/12 · New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations · Persbericht

16/12 · Paranovus Entertainment Technology Limited Announces 1-For-100 Reverse Share Split · Persbericht

16/12 · Trust Your Gut--USANA's Probiotic Earns ConsumerLab.com Seal of Approval · Persbericht

16/12 · VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm · Persbericht

15/12 · AB Science announces a new publication on biorxiv that identifies AB8939 as a promising drug candidate for treating refractory acute myeloid leukemia and potentially other cancers · Persbericht

15/12 · Ipsen completes acquisition of ImCheck Therapeutics, expanding oncology pipeline · Persbericht

12/12 · Novo Nordisk A/S: More efficacious dose of Wegovy® recommended by the European Medicines Agency can help people with obesity achieve an average of 20.7% weight loss · Persbericht

11/12 · AB Science announces new publication on Medrxiv highlighting clinical benefit with masitinib in Amyotrophic Lateral Sclerosis patients prior any complete loss of function · Persbericht

11/12 · Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland · Persbericht

10/12 · Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+ · Persbericht

9/12 · IPSEN - Buy-back programme - Art 5 of MAR - Week 49- 2025 · Persbericht

9/12 · Novo Nordisk has completed its acquisition of Akero Therapeutics · Persbericht

Mijn selecties